Laura Iavarone

548 total citations
25 papers, 417 citations indexed

About

Laura Iavarone is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Laura Iavarone has authored 25 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Laura Iavarone's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Laura Iavarone is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Laura Iavarone collaborates with scholars based in Italy, United Kingdom and United States. Laura Iavarone's co-authors include Richard P. Butt, Aoibhinn McDonnell, Susie M. Collins, Zahid Ali, Simon Kirby, Lisa Squassante, Stefano Milleri, Roberto Goméni, Alan Bye and Vincenzo Teneggi and has published in prestigious journals such as NeuroImage, Pain and International Journal of Molecular Sciences.

In The Last Decade

Laura Iavarone

24 papers receiving 404 citations

Peers

Countries citing papers authored by Laura Iavarone

Since Specialization

Citations

This map shows the geographic impact of Laura Iavarone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Iavarone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Iavarone more than expected).

Fields of papers citing papers by Laura Iavarone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Iavarone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Iavarone. The network helps show where Laura Iavarone may publish in the future.

Co-authorship network of co-authors of Laura Iavarone

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Iavarone. A scholar is included among the top collaborators of Laura Iavarone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Iavarone. Laura Iavarone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology 2025 ·International Journal of Molecular Sciences ·Laura Iavarone, (unknown), Federica Zito Marino, (unknown), Giuseppe Argenziano, (unknown), (unknown), (unknown), Gerardo Cazzato	0
2	Mechanistic pharmacokinetic–pharmacodynamic modeling and simulations of naloxone auto‐injector 10 mg reversal of opioid‐induced respiratory depression 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), Laura Iavarone, Jianping Zhang, Joseph Kim, (unknown), (unknown)	1
3	A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects 2020 ·Clinical Drug Investigation ·Niels‐Peter Becker, Annekathrin Haberland, Katrin Wenzel, (unknown), Gerd Wallukat, (unknown), Sarah Schulze-Rothe, (unknown), Ingolf Schimke, Sabine Bartel, Matthias Großmann, (unknown), Laura Iavarone, Jan H. Boergermann, Kiley R. Prilliman, Georg Golor, Johannes Müller, Susanne Becker	16
4	Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy 2018 ·Pain ·Aoibhinn McDonnell, Susie M. Collins, Zahid Ali, Laura Iavarone, (unknown), Simon Kirby, Richard P. Butt	111
5	Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels 2016 ·Clinical Pharmacokinetics ·Hannah M. Jones, Richard P. Butt, Rob Webster, Ian Gurrell, Paweł Dżygiel, (unknown), Daniela Fraier, (unknown), Laura Iavarone, (unknown), (unknown), Alex Phipps, (unknown), (unknown), Kevin Beaumont	22
6	In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography 2014 ·Neuropharmacology ·Robert A. Comley, Jasper van der Aart, Balázs Gulyás, Martine Garnier, Laura Iavarone, Christer Halldin, Eugenii A. Rabiner	2
7	Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Robert A. Comley, Cristian Salinas, Mark Slifstein, Marcella Petrone, (unknown), Idriss Bennacef, Paul Shotbolt, Jasper van der Aart, (unknown), Laura Iavarone, Roberto Goméni, Marc Laruelle, (unknown), Roger N. Gunn, Eugenii A. Rabiner	15
8	Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach 2012 ·Neuropsychopharmacology ·Manolo Mugnaini, Laura Iavarone, (unknown), Cristiana Griffante, Beatrice Oliosi, (unknown), John D. Beaver, Eugenii A. Rabiner, Fabrizio Micheli, Christian Heidbreder, Anne C. Andorn, Emilio Merlo Pich, Massimo Bani	68
9	Pharmacokinetics and central nervous system effects of the novel dopamine D₃receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state 2012 ·Journal of Psychopharmacology ·(unknown), (unknown), Massimo Bani, Anne C. Andorn, Laura Iavarone, (unknown), (unknown), JMA van Gerven	5
10	Dose‐Related Reduction in Bupropion Plasma Concentrations by Ritonavir 2010 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Claire Brittain, Donavon J. McConn, Laura Iavarone, John A. Ascher, Suzanne M. Sutherland, Keith T. Muir	31
11	Bupropion Has No Effect on Intraocular Pressure or Other Ophthalmologic Parameters After Single or Repeat Doses in Healthy Volunteers 2009 ·The Journal of Clinical Pharmacology ·Giulia Ghibellini, Joo‐Hyun Park, Claire Brittain, Laura Iavarone, Anne C. Andorn, Norman S. Levy, Keith T. Muir	2
12	An Application of Nonlinear Mixed-Effects Modeling to Pharmacokinetic Data Exhibiting Nonlinear and Time-Dependent Behavior 2002 ·Journal of Pharmaceutical Sciences ·Laura Iavarone, Roberto Goméni	3
13	Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal‐induced craving 2002 ·British Journal of Clinical Pharmacology ·Vincenzo Teneggi, Lisa Squassante, Laura Iavarone, Stefano Milleri, Alan Bye, Roberto Goméni	33
14	The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects 2001 ·British Journal of Clinical Pharmacology ·Luigi Ziviani, (unknown), Lisa Squassante, Stefano Milleri, (unknown), Laura Iavarone	20
15	Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: indirect response and probabilistic modeling. 2001 ·Pharmaceutical Research ·Roberto Goméni, Vincenzo Teneggi, Laura Iavarone, Lisa Squassante, Alan Bye	16
16	The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects 2001 ·British Journal of Clinical Pharmacology ·Luigi Ziviani, (unknown), Lisa Squassante, Stefano Milleri, (unknown), Laura Iavarone	3
17	First Time in Human for GV196771: Interspecies Scaling Applied on Dose Selection 1999 ·The Journal of Clinical Pharmacology ·Laura Iavarone, John F. Hoke, (unknown), Robert J. Barnaby, G. C. Preston	21
18	Sanfetrinem and sanfetrinem-cilexetil: disposition in rat and dog 1997 ·Xenobiotica ·Laura Iavarone, (unknown), (unknown), (unknown), (unknown)	8
19	Qualitative analysis of potential metabolites and degradation products of a new antiinfective drug in rat urine, using HPLC with radiochemical detection and HPLC-mass spectrometry 1995 ·Journal of Pharmaceutical and Biomedical Analysis ·Laura Iavarone, (unknown), (unknown), (unknown)	5
20	Efficient Production of the Cyclosporin Metabolite AM1 By Rabbit Hepatic Enzymes 1993 ·Pharmacological Research ·Rita Paroni, Isabella Fermo, Laura Iavarone, Marina Del Puppo, L. De Angelis, M. Galli Kienle	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact